Thank you Osi, sorry I'm not sure I understand. You say that if someone is clearly sick then the test will work. So why test this group? And no point in testing those newly presenting with the symptons as the test is inaccurate there, nor those that don't have symptons, right? There's a pandemic on, are we really going to be unsure about who to triage amongst the obviously sick?I see a market to test people for immunity so they can return to the coal face, but the cry of "test everyone, again and again," I don't get, given the tests limitations.
I know you and T7 have a good grounding in all this. I don't. I'm not trying to be the party pooper some on here are ignorantly making me out to be, but I get all that. It's HC. My intent is simply to throw caution in there for new followers.
- Forums
- ASX - By Stock
- AN1
- Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement, page-149
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable